Company · CIK 1839970
BlossomHill Therapeutics, Inc.
| CIK | 1839970 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BLSM (Nasdaq) |
| First annual or quarterly report | 2026-09-18 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297512 | 2026-07-17 | 2026-08-07 | 4 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-07 | 424B4Final prospectus | 333-297512 | 0001193125-26-340215 |
| 2026-08-06 | EFFECTDeclared effective | 333-297512 | 9999999995-26-002565 |
| 2026-08-03 | S-1/AAmendment | 333-297512 | 0001193125-26-329416 |
| 2026-07-17 | S-1Registration filed | 333-297512 | 0001193125-26-306506 |
| 2026-04-24 | DRSDraft made public | 377-09295 | 0001193125-26-177693 |